What is it about?
The paper provides current evidence on the use of rifaximin in diverticular disease
Featured Image
Photo by CDC on Unsplash
Read the Original
This page is a summary of: Diverticular Disease and Rifaximin: An Evidence-Based Review, Antibiotics, February 2023, MDPI AG,
DOI: 10.3390/antibiotics12030443.
You can read the full text:
Contributors
The following have contributed to this page
